<DOC>
	<DOCNO>NCT02075125</DOCNO>
	<brief_summary>To compare efficacy safety prasugrel ticagrelor patient ST-segment elevation myocardial infarction undergo primary percutaneous coronary intervention .</brief_summary>
	<brief_title>Prasugrel Ticagrelor ST-segment Elevation Myocardial Infarction</brief_title>
	<detailed_description>Prasugrel ticagrelor recommend patient ST-segment elevation myocardial infarction ( STEMI ) undergo primary percutaneous coronary intervention ( PCI ) . Both prasugrel ticagrelor show rapid potent antiplatelet effect compare clopidogrel . However , previous report compare efficacy safety prasugrel ticagrelor patient STEMI East Asian ethnicity lacking . Therefore , aim study compare antiplatelet efficacy safety use laboratory platelet function test clinical outcome patient STEMI treat either prasugrel ticagrelor .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Prasugrel Hydrochloride</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>Patients STsegment elevation myocardial infarction Undergoing primary percutaneous coronary intervention Aged 20 80 year Previous administration antagonist platelet adenosine diphosphate ( ADP ) P2Y12 receptor ( clopidogrel , prasugrel ticagrelor ) History stroke transient ischemic attack Previous gastrointestinal bleeding within 6 month , bleed diathesis , platelet count &lt; 100,000/mm3 hemoglobin &lt; 10 g/dl Chronic oral anticoagulation treatment Contraindication antiplatelet treatment Severe renal insufficiency ( serum creatine &gt; 2.5 mg/dl ) Severe hepatic dysfunction ( serum liver enzyme bilirubin &gt; 3 time normal limit ) Sever chronic obstructive pulmonary disease ( COPD ) bradycardia Body weight &lt; 50 kg</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Korea</keyword>
	<keyword>Platelet inhibition</keyword>
	<keyword>Prasugrel</keyword>
	<keyword>Ticagrelor</keyword>
	<keyword>ST-segment elevation myocardial infarction</keyword>
</DOC>